Sign in

CIK 0000908259

  • Non-accelerated filer
  • Smaller reporting company

Oncotelic Therapeutics, Inc.

Sign in to watch
Ticker
OTLC
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133679168
Phone
+1 650-635-7000
Business address
29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
Former names
MATEON THERAPEUTICS INC, OXIGENE INC
Open-market buys, last 90 days
$23,537
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Trieu Vuong +$24K CHAIRMAN AND CEO 1 filing
Date Insider Transaction Shares Price Value Owned after
2018-06-20 CHAPLIN DAVID Director Grant or award · Stock Option (Right to Buy) +258,171 258,171
2017-01-12 CHAPLIN DAVID Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +262,500 $0.38 $98K 262,500
2016-03-21 CHAPLIN DAVID Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +262,500 262,500
2015-05-28 CHAPLIN DAVID Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +225,000 225,000
2014-05-15 CHAPLIN DAVID President and CEO Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000
2014-01-02 CHAPLIN DAVID Director Grant or award · Stock Option (Right to Buy) +4,880 4,880
2013-07-01 CHAPLIN DAVID Director Grant or award · Stock Option (Right to Buy) +10,060 10,060
2013-01-23 CHAPLIN DAVID Director Grant or award · Stock Option (Right to Buy) +6,260 6,260
2010-09-15 CHAPLIN DAVID Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2010-04-27 CHAPLIN DAVID Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +400,000 400,000
2009-01-20 CHAPLIN DAVID Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +120,000 120,000
2007-01-25 CHAPLIN DAVID Chief Scientific Officer Grant or award · Option to Purchase Common Stock +25,000 25,000
2005-10-03 CHAPLIN DAVID Chief Scientific Officer Grant or award +80,000 131,100
2005-07-15 CHAPLIN DAVID Chief Scientific Officer Grant or award +80,000 131,100
2004-07-28 CHAPLIN DAVID Chief Scientific Officer Grant or award · Options to purchase Common Stock +50,000 50,000
2004-05-21 CHAPLIN DAVID Chief Scientific Officer Purchase +200 $7.47 $1K 200
2004-05-21 CHAPLIN DAVID Chief Scientific Officer Purchase +1,500 $7.46 $11K 1,700
2004-05-21 CHAPLIN DAVID Chief Scientific Officer Purchase +200 $7.45 $1K 1,900
2004-05-21 CHAPLIN DAVID Chief Scientific Officer Purchase +100 $7.38 $738 2,000

Page 1 of 1 · 19 trades